前往化源商城

Chemical & Pharmaceutical Bulletin 2014-01-01

Practical method for preparing nanosuspension formulations for toxicology studies in the discovery stage: formulation optimization and in vitro/in vivo evaluation of nanosized poorly water-soluble compounds.

Takao Komasaka, Hisako Fujimura, Toshiaki Tagawa, Akio Sugiyama, Yasunori Kitano

文献索引:Chem. Pharm. Bull. 62(11) , 1073-82, (2014)

全文:HTML全文

摘要

The present study aimed to develop a practical method for preparing nanosuspension formulations of poorly water-soluble compounds for enhancing oral absorption in toxicology studies in the discovery stage. To obtain a suitable nanosuspension formulation for the intended purpose, formulations were optimized with a focus on the following characteristics: i) containing a high drug concentration, ii) consisting of commonly used excipient types in proper quantities for toxicology studies, iii) having long-term stability, and iv) having versatility for use with diverse compounds. Test compounds were milled with various excipients by wet media milling methods using a mixer mill (10 mg/batch) and a rotation/revolution mixer (0.5 g/batch). As a result, 100 mg/mL nanosuspensions of all 11 test compounds could be prepared with an optimized dispersing agent, 0.5% hydroxypropyl methylcellulose (HPMC) (3 cP)-0.5% Tween 80. Notably, it was found that the molecular weight of HPMC influenced not only particle size but also the stability of nanosuspensions and they were stable for 4 weeks at 5°C. The nanosuspensions increased in vitro dissolution rates and provided 3.9 and 3.0 times higher Cmax and 4.4 and 1.6 times higher area under the concentration-time curve from 0-24 h (AUC0-24 h) in rats (oral dose of 300 mg/kg) for cilostazol and danazol, respectively. In conclusion, applying a wet media milling method with the combination of HPMC of a small molecular weight and Tween 80 as a dispersing agent, nanosuspensions can be practically prepared and conveniently utilized for enhancing the oral absorption of poorly water-soluble compounds in toxicology studies in the discovery stage.

相关化合物

结构式 名称/CAS号 全部文献
吡罗昔康 结构式 吡罗昔康
CAS:36322-90-4
萘普生 结构式 萘普生
CAS:22204-53-1
十二烷基硫酸钠 结构式 十二烷基硫酸钠
CAS:151-21-3
牛磺胆酸钠 结构式 牛磺胆酸钠
CAS:145-42-6
L-赖氨酸盐酸盐 结构式 L-赖氨酸盐酸盐
CAS:657-27-2
呋噻米 结构式 呋噻米
CAS:54-31-9
苯妥英 结构式 苯妥英
CAS:57-41-0
硝苯地平 结构式 硝苯地平
CAS:21829-25-4
西洛他唑 结构式 西洛他唑
CAS:73963-72-1
达那唑 结构式 达那唑
CAS:17230-88-5